<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01537393</url>
  </required_header>
  <id_info>
    <org_study_id>CPTS</org_study_id>
    <secondary_id>1U10EY020798-01A1</secondary_id>
    <secondary_id>1U10EY020797-01A1</secondary_id>
    <nct_id>NCT01537393</nct_id>
  </id_info>
  <brief_title>Cornea Preservation Time Study</brief_title>
  <acronym>CPTS</acronym>
  <official_title>Effect of Corneal Preservation Time on Long-Term Graft Success</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jaeb Center for Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Case Western Reserve University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the 3-year graft failure rate following
      endothelial keratoplasty performed with donor corneas with a preservation time of 8 to 14
      days is non-inferior to the failure rate when donor corneas with a preservation time of 7 or
      fewer days are used.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When the donor cornea is removed from the person who died, it is prepared for transplantation
      by an eye bank. The donor cornea is placed into a liquid that helps preserve the cornea until
      it is transplanted. The Food and Drug Administration (FDA) has approved storage of the cornea
      in this liquid for up to 14 days before the transplant. The purpose of this study is to see
      if the length of time the donor cornea is kept in the preservation liquid before the
      transplant affects the likelihood of the transplant being successful. We will follow
      participants for 3 years after transplant to see if there are any differences in transplant
      success or in the number of transplanted endothelial cells (the layer of cells that line the
      undersurface of the cornea) on the corneas that were preserved for 7 days or less compared to
      those preserved between 8 and 14 days. We have no reason to believe that there is any greater
      risk for transplant failure with either preservation time group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 16, 2012</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery</measure>
    <time_frame>Study eye will be assessed for this outcome for 3 years following surgery</time_frame>
    <description>Graft failure, defined as the occurrence of one of the following within 3 years of surgery:
Regrafting of the study eye for any reason
Cornea which remains cloudy without clearing, according to the following:
cloudy cornea on the first postoperative day which does not clear within 8 weeks OR
cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial Cell Density (ECD)</measure>
    <time_frame>3 years from surgery</time_frame>
    <description>Endothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1174</enrollment>
  <condition>Cornea Preservation Time</condition>
  <condition>Endothelial Keratoplasty</condition>
  <condition>Transplant Success</condition>
  <condition>Endothelial Cell Density</condition>
  <arm_group>
    <arm_group_label>0-7d Preservation Time Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects in this arm will receive cornea tissue transplant with cornea tissue preserved for 0 to 7 days prior to transplant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8-14d Preservation Time Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects in this arm will receive cornea tissue transplant with cornea tissue preserved for 8 to 14 days prior to transplant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cornea tissue transplant</intervention_name>
    <description>Cornea tissue preserved 0 to 7 days</description>
    <arm_group_label>0-7d Preservation Time Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cornea tissue transplant</intervention_name>
    <description>Cornea tissue preserved 8 to 14 days.</description>
    <arm_group_label>8-14d Preservation Time Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Study Participant Eligibility Criteria

          -  Study Participant Inclusion Criteria

               1. Age range 30-&lt;91 years with minimum life expectancy of at least 3 years.

               2. Willingness to return for follow-up study visits at 1 day, 1 week, 1 month, 6
                  months, 1 year, 2 years and 3 years.

               3. Fluent in English or Spanish.

          -  Study Participant Exclusion Criteria 1) Decisionally and/or cognitively impaired

        Study Eye Eligibility Criteria

          -  Study Eye Inclusion Criteria

               1. Endothelial keratoplasty (EK) is scheduled between 10 and 60 days after
                  enrollment

                    -  The 10-day requirement relates to the need to be able to randomly assign the
                       eye to either intervention group.

                    -  The 60-day requirement relates to the need to have current eligibility and
                       enrollment data at the time of surgery. If surgery is postponed to &gt;60 days
                       after the initial enrollment visit, a new Baseline Visit and eligibility
                       assessment will have to be performed.

               2. Presence of a condition related to endothelial dysfunction which will be treated
                  by EK.

          -  Eligible indications for EK include:

               -  Presence of Fuchs endothelial corneal dystrophy (FECD) meeting at least one of
                  the following:

                    -  Phakic FECD

                    -  Phakic FECD with cataract

                         -  Triple procedure including EK for FECD, cataract extraction and
                            posterior chamber intraocular lens implantation (IOL) is allowed

                    -  Aphakic FECD

                    -  Pseudophakic FECD with posterior capsule supported, suture-fixated, or
                       sulcus-supported posterior chamber IOL

               -  Aphakic or pseudophakic corneal edema with posterior capsule supported,
                  suture-fixated, or sulcus-supported posterior chamber IOL without FECD

          -  Study Eye Exclusion Criteria

               1. Prior EK

               2. Indication for surgery that is not suitable for EK (e.g, keratoconus, stromal
                  dystrophies and scars)

               3. Presence of a condition that has a very high probability for failure (e.g.,
                  failed EK or Penetrating Keratoplasty (PKP), heavily vascularized cornea,
                  uncontrolled uveitis)

               4. Other primary endothelial dysfunction conditions including posterior polymorphous
                  corneal dystrophy and congenital hereditary corneal dystrophy

               5. Anterior chamber IOL in study eye prior to or anticipated during EK

               6. Planned intraocular lens exchange of an anterior chamber IOL with a posterior
                  chamber IOL in study eye at time of study EK

               7. Pre-operative central sub-epithelial or stromal scarring that the investigator
                  believes is visually significant and could impact post-operative stromal clarity
                  assessment

               8. Stromal vascularization that is visually significant (by investigator's judgment)

               9. Presence of anterior synechiae (iris to cornea)

              10. Peripheral anterior synechiae (iris to angle) in the angle greater than a total
                  of three clock hours

              11. Hypotony (Intraocular pressure &lt;10 mm Hg)

              12. Uncontrolled (defined as intraocular pressure &gt; 25mm Hg) glaucoma with or without
                  prior filtering surgery or shunt or mini-shunt placement.

                    -  A shunt or mini-shunt is any device implanted to lower intraocular pressure
                       through an external route (e.g Ahmed) or internal route (e.g. Glaukos) that
                       is present in the anterior chamber angle or extends into the anterior
                       chamber.

              13. Controlled glaucoma with prior shunt or mini-shunt placement for glaucoma

                    -  Note: FECD or pseudophakic/aphakic corneal edema with posterior chamber IOL
                       that also have undergone filtering surgery (without shunt or mini-shunt) in
                       which glaucoma is currently considered under control will be eligible

              14. Fellow eye visual acuity &lt; 20/200 that is not correctable with EK

        Eligibility Criteria for Second Study Eye

          1. Study participant has already enrolled one eye

          2. The second eye meets all study eye inclusion and exclusion criteria (2.2.2 and 2.2.3)

          3. EK surgery in second eye is not planned within 6 weeks of EK on first study eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Lass, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Case Western Reserve University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Allison Ayala, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jaeb Center for Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keck Medical Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jules Stein Eye Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Care of San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bascom Palmer Eye Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sight</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Woolfson Eye Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Consultants of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois Eye and Eye</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Ophthalmology</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mid-Atlantic Cornea Consultants</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins/Wilmer Eye Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Consultants of Maryland</name>
      <address>
        <city>Owings Mills</city>
        <state>Maryland</state>
        <zip>21117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan/Kellogg Eye Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Verdier Eye Center</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49546</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Cornea Consultants</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Eye Consultants</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmology Associates</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Research Institute</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Eye and Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornea Consultants of Albany</name>
      <address>
        <city>Slingerlands</city>
        <state>New York</state>
        <zip>12159</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Eye Institute</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center Eye Institute</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Ohio Eye Surgeons</name>
      <address>
        <city>Kent</city>
        <state>Ohio</state>
        <zip>44240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Eye Center</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Devers Eye Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Partners of PA</name>
      <address>
        <city>Bala-Cynwyd</city>
        <state>Pennsylvania</state>
        <zip>19053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Pennsylvania Eye Institute</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sadeer Hannush, MD</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <zip>19047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Corneal Associates, PC, Wills Eye Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornea Associates of Texas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Focal Point Vision</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah, Moran Eye Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Associates Northwest</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dean Medical Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://cpts.jaeb.org/</url>
    <description>Public website</description>
  </link>
  <results_reference>
    <citation>Rosenwasser GO, Szczotka-Flynn LB, Ayala AR, Liang W, Aldave AJ, Dunn SP, McCall T, Navarro LC, Pramanik S, Ross KW, Stulting RD, Terry MA, Tu EY, Verdier DD, Kollman C, Gal RL, Beck RW, Lass JH; Cornea Preservation Time Study Group. Effect of Cornea Preservation Time on Success of Descemet Stripping Automated Endothelial Keratoplasty: A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Dec 1;135(12):1401-1409. doi: 10.1001/jamaophthalmol.2017.4989.</citation>
    <PMID>29127431</PMID>
  </results_reference>
  <results_reference>
    <citation>Lass JH, Benetz BA, Verdier DD, Szczotka-Flynn LB, Ayala AR, Liang W, Aldave AJ, Dunn SP, McCall T, Mian SI, Navarro LC, Patel SV, Pramanik S, Rosenwasser GO, Ross KW, Terry MA, Kollman C, Gal RL, Beck RW; Cornea Preservation Time Study Group. Corneal Endothelial Cell Loss 3 Years After Successful Descemet Stripping Automated Endothelial Keratoplasty in the Cornea Preservation Time Study: A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Dec 1;135(12):1394-1400. doi: 10.1001/jamaophthalmol.2017.4970.</citation>
    <PMID>29127432</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2012</study_first_posted>
  <results_first_submitted>March 14, 2018</results_first_submitted>
  <results_first_submitted_qc>April 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">April 23, 2018</results_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Case Western Reserve University</investigator_affiliation>
    <investigator_full_name>Jonathan Lass, MD</investigator_full_name>
    <investigator_title>Charles I Thomas Professor, Dept. of Ophthalmology &amp; Visual Sciences,</investigator_title>
  </responsible_party>
  <keyword>cornea</keyword>
  <keyword>transplant</keyword>
  <keyword>preservation</keyword>
  <keyword>endothelial keratoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Randomization was at eye level. When both eyes of a participant were included, the eye undergoing surgery 1st was assigned randomly to a PT group and the 2nd eye to the other group. 2 eyes had their assigned donor corneas inadvertently switched, and resulted in 1 of these participants receiving both study eyes from 8-14d group.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>0-7d Preservation Time (PT) Group</title>
          <description>Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
        <group group_id="P2">
          <title>8-14d Preservation Time (PT) Group</title>
          <description>Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="707"/>
                <participants group_id="P2" count="698"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="553"/>
                <participants group_id="P2" count="507"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="154"/>
                <participants group_id="P2" count="191"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Exclude prior to study</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failure - Regrafted</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failure - Not regrafted</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Censored (severe event unrelated to PT)</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analyses conducted at eye level. 1330 study eyes of 1090 participants underwent descemet stripping automated endothelial keratoplasty. 480 eyes completed bilateral surgery (240 participants), 1 participant had both eyes received cornea in 8-14 days group. 435 and 414 participants underwent unilateral surgery in 0-7 and 8-14 days groups.</population>
      <group_list>
        <group group_id="B1">
          <title>Preservation Time Group 1</title>
          <description>Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
        <group group_id="B2">
          <title>Preservation Time Group 2</title>
          <description>Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="675"/>
            <count group_id="B2" value="654"/>
            <count group_id="B3" value="1090"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>eyes</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="675"/>
            <count group_id="B2" value="655"/>
            <count group_id="B3" value="1330"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" lower_limit="64" upper_limit="76"/>
                    <measurement group_id="B2" value="70" lower_limit="64" upper_limit="77"/>
                    <measurement group_id="B3" value="70" lower_limit="64" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="409"/>
                    <measurement group_id="B2" value="392"/>
                    <measurement group_id="B3" value="801"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="266"/>
                    <measurement group_id="B2" value="263"/>
                    <measurement group_id="B3" value="529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="613"/>
                    <measurement group_id="B2" value="594"/>
                    <measurement group_id="B3" value="1207"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>American India or Alaskan Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than 1 race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or not reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Diabetes</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current cigarette smoker</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Received any immunizations or vaccinations in last 3 mo</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior glaucoma surgery</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glaucoma medication currently being used</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosis</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Pseudophakic corneal edema without FECD</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Aphakic corneal edema without FECD</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fuchs endothelial corneal dystrophy (FECD)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="631"/>
                    <measurement group_id="B2" value="624"/>
                    <measurement group_id="B3" value="1255"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))</title>
          <description>During the slit lamp exam performed using the investigator's usual routine, the presence of other corneal dystrophies was recorded; EBMD=epithelial basement membrane dystrophy</description>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="630"/>
                    <measurement group_id="B2" value="623"/>
                    <measurement group_id="B3" value="1253"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Keratoconus</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>EBMD (epithelial basement membrane dystrophy)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stromal corneal vessels present (but not visually significant)</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Central subepithelial/stromal scarring present (not affect postoperative stromal clarity assessment)</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peripheral anterior synechiae present (nongonioscopic)</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative lens status</title>
          <description>During the slit lamp exam performed using the investigator's usual routine, the state of the crystalline lens was described as phakic (present), aphakic (removed), or pseudophakic (removed with posterior chamber intraocular lens inserted)</description>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Phakic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="341"/>
                    <measurement group_id="B2" value="351"/>
                    <measurement group_id="B3" value="692"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Aphakic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Pseudophakic posterior chamber intraocular lens</title>
                  <measurement_list>
                    <measurement group_id="B1" value="334"/>
                    <measurement group_id="B2" value="302"/>
                    <measurement group_id="B3" value="636"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Postoperative lens status</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Phakic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Pseudophakic posterior chamber intraocular lens</title>
                  <measurement_list>
                    <measurement group_id="B1" value="671"/>
                    <measurement group_id="B2" value="649"/>
                    <measurement group_id="B3" value="1320"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intraocular pressure (IOP)</title>
          <units>mm Hg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15" lower_limit="12" upper_limit="17"/>
                    <measurement group_id="B2" value="15" lower_limit="12" upper_limit="17"/>
                    <measurement group_id="B3" value="15" lower_limit="12" upper_limit="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery</title>
        <description>Graft failure, defined as the occurrence of one of the following within 3 years of surgery:
Regrafting of the study eye for any reason
Cornea which remains cloudy without clearing, according to the following:
cloudy cornea on the first postoperative day which does not clear within 8 weeks OR
cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.</description>
        <time_frame>Study eye will be assessed for this outcome for 3 years following surgery</time_frame>
        <population>Analyzed number of eyes in each group (Overall 1090 unique participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Preservation Time Group 1</title>
            <description>Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
          </group>
          <group group_id="O2">
            <title>Preservation Time Group 2</title>
            <description>Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery</title>
          <description>Graft failure, defined as the occurrence of one of the following within 3 years of surgery:
Regrafting of the study eye for any reason
Cornea which remains cloudy without clearing, according to the following:
cloudy cornea on the first postoperative day which does not clear within 8 weeks OR
cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.</description>
          <population>Analyzed number of eyes in each group (Overall 1090 unique participants)</population>
          <units>Eyes</units>
          <param>Count of Units</param>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="675"/>
                <count group_id="O2" value="654"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="675"/>
                <count group_id="O2" value="655"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>The two treatment groups will be declared equivalent if the one-sided 95% confidence interval for the difference in proportions excludes the pre-defined non-inferiority limit of 4%.</non_inferiority_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>3.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>5.4</ci_upper_limit>
            <other_analysis_desc>The bootstrap re-sampling technique were used to account for potentially correlated data from donors who donated both corneas in this study and potentially correlated data from 2 study eyes of the same study participant. The technique will sample with replacement from the observed dataset. Confidence intervals will be calculated using the bias-corrected and accelerated method. The number of bootstraps will be 100,000.</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Confounding and treatment interactions were assessed in Cox proportional hazards regression models</non_inferiority_desc>
            <p_value>0.02</p_value>
            <method>Regression, Cox</method>
            <method_desc>Unadjusted Hazard Ratio</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.09</ci_lower_limit>
            <ci_upper_limit>2.71</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Endothelial Cell Density (ECD)</title>
        <description>Endothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.</description>
        <time_frame>3 years from surgery</time_frame>
        <population>Eyes with graft success and a gradable image at 3 year (945 eyes of 769 unique participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Preservation Time Group 1</title>
            <description>Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
          </group>
          <group group_id="O2">
            <title>Preservation Time Group 2</title>
            <description>Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelial Cell Density (ECD)</title>
          <description>Endothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.</description>
          <population>Eyes with graft success and a gradable image at 3 year (945 eyes of 769 unique participants)</population>
          <units>Cells per square millimeter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="459"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="460"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1722" spread="626"/>
                    <measurement group_id="O2" value="1642" spread="631"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The primary analysis to assess the effect of PT on 3 year ECD was conducted with a mixed linear model adjusting for baseline ECD, corneal diagnosis, and potential confounders, including storage solution, preparation by eye bank vs surgeon, and accounting for correlated data from participants with 2 study eyes or 2 corneas from the same donor.</non_inferiority_desc>
            <p_value>0.03</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Adjusted for baseline ECD, diagnosis, storage solution, preparation by eye bank/surgeon, participants with 2 study eyes/ 2 corneas from the same donor</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>73</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>8</ci_lower_limit>
            <ci_upper_limit>138</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through study completion, up to 5 years</time_frame>
      <desc>Adverse event was collected at eye level</desc>
      <group_list>
        <group group_id="E1">
          <title>0-7d Preservation Time Group</title>
          <description>Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
        <group group_id="E2">
          <title>8-14d Preservation Time Group</title>
          <description>Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant.
Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="675"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="654"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="675"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="654"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <description>One case of bacterial endophthalmitis occurred in the 0-7d PT group 4 days after surgery</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="675"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="654"/>
              </event>
              <event>
                <sub_title>Microbial keratitis</sub_title>
                <description>Microbial keratitis (bacterial, fungal, parasitic) within 3 months of endothelial keratoplasty (EK) 2 cases of fungal keratitis occurred in the 8-14d PT group 13 and 43 days after surgery</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="675"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="654"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="675"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="654"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jonathan Lass</name_or_title>
      <organization>CaseWestern</organization>
      <phone>2168448368</phone>
      <email>Jonathan.Lass@UHhospitals.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

